Evidence map›Paper›PMID 23034120›Full record

ArticleGenome biology2012

Chromatin accessibility reveals insights into androgen receptor activation and transcriptional specificity.

Alok K Tewari, Galip Gürkan Yardimci, Yoichiro Shibata, Nathan C Sheffield, Lingyun Song, Barry S Taylor, Stoyan G Georgiev, Gerhard A Coetzee, Uwe Ohler, Terrence S Furey and 2 more

Open access · goldAbstract read
In one paragraph

Article in Genome biology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed
9.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 82 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Analytical Approaches for ATAC-seq Data Analysis.Current protocols in human genetics · 2020
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 1 country.

Alok K Tewari
Galip Gürkan Yardimci
Yoichiro Shibata
Nathan C Sheffield
Lingyun Song
Barry S Taylor
Stoyan G Georgiev
Gerhard A Coetzee
Uwe Ohler
Terrence S Furey
Gregory E Crawford
Phillip G Febbo
Duke University · USMemorial Sloan Kettering Cancer Center · USUCSF Helen Diller Family Comprehensive Cancer Center · USUniversity of North Carolina at Chapel Hill · USUniversity of Southern California · US

Funding

Comprehensive Identification of Active Functional Elements in Human ChromatinU54HG004563 · NHGRI · DUKE UNIVERSITY · PI CRAWFORD, GREGORY E · 2007 to 2011
$9.7M
Prostate Cancer Risk EnhancersR01CA136924 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI COETZEE, GERHARD A, FARNHAM, PEGGY J · 2010 to 2019
$5.4M
AR and RUNX2 target genes in prostate cancerR01CA109147 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI COETZEE, GERHARD A · 2006 to 2010
$1.3M
NCI NIH HHS R01CA109147NCI NIH HHS R01CA136924NHGRI NIH HHS U54 HG004563
6 · The paper itself

Abstract

backgroundEpigenetic mechanisms such as chromatin accessibility impact transcription factor binding to DNA and transcriptional specificity. The androgen receptor (AR), a master regulator of the male phenotype and prostate cancer pathogenesis, acts primarily through ligand-activated transcription of target genes. Although several determinants of AR transcriptional specificity have been elucidated, our understanding of the interplay between chromatin accessibility and AR function remains incomplete.

resultsWe used deep sequencing to assess chromatin structure via DNase I hypersensitivity and mRNA abundance, and paired these datasets with three independent AR ChIP-seq datasets. Our analysis revealed qualitative and quantitative differences in chromatin accessibility that corresponded to both AR binding and an enrichment of motifs for potential collaborating factors, one of which was identified as SP1. These quantitative differences were significantly associated with AR-regulated mRNA transcription across the genome. Base-pair resolution of the DNase I cleavage profile revealed three distinct footprinting patterns associated with the AR-DNA interaction, suggesting multiple modes of AR interaction with the genome.

conclusionsIn contrast with other DNA-binding factors, AR binding to the genome does not only target regions that are accessible to DNase I cleavage prior to hormone induction. AR binding is invariably associated with an increase in chromatin accessibility and, consequently, changes in gene expression. Furthermore, we present the first in vivo evidence that a significant fraction of AR binds only to half of the full AR DNA motif. These findings indicate a dynamic quantitative relationship between chromatin structure and AR-DNA binding that impacts AR transcriptional specificity.

Indexed as

Transcription, GeneticBinding SitesCell Line, TumorChromatinGene Expression Regulation, NeoplasticGenome, HumanHigh-Throughput Nucleotide SequencingHumansMaleMetriboloneReceptors, AndrogenSequence Analysis, DNASp1 Transcription FactorAR protein, humanChromatinMetriboloneReceptors, AndrogenSP1 protein, humanSp1 Transcription Factor

Identifiers

PMID23034120
PMCPMC3491416
OpenAlexW2105623411

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.